Genzyme Receives FDA Response Letter on Synvisc-One(TM) (The San Francisco Examiner)
CAMBRIDGE, Mass. ( Map ) - CAMBRIDGE, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Genzyme Corp. (Nasdaq: GENZ ) announced today that it has received a letter from the U.S.

Richard A. Miller: Innovating the FDA -- With the Drug Industry's Help? (HuffingtonPost)
Over the past decade, the number of new drug approvals has actually declined despite substantial increases in federal and private sector funding of biomedical research.